We examined the osteoblast/osteocyte expression and function of polycystin-1 (PC1), a transmembrane protein that is a component of the polycystin-2 (PC2)-ciliary mechano-sensor complex in renal epithelial cells. We found that MC3T3-E1 osteoblasts and MLO-Y4 osteocytes express transcripts for PC1, PC2, and the ciliary proteins Tg737 and Kif3a. Immunohistochemical analysis detected cilia-like structures in MC3T3-E1 osteoblastic and MLO-Y4 osteocyte-like cell lines as well as primary osteocytes and osteoblasts from calvaria. Pkd1 m1Bei mice have inactivating missense mutations of Pkd1 gene that encode PC1. Pkd1 m1Bei homozygous mutant mice demonstrated delayed endochondral and intramembranous bone formation, whereas heterozygous Pkd1 m1Bei mutant mice had osteopenia caused by reduced osteoblastic function. Heterozygous and homozygous Pkd1 m1Bei mutant mice displayed a gene dose-dependent decrease in the expression of Runx2 and osteoblastrelated genes. In addition, overexpression of constitutively active PC1 C-terminal constructs in MC3T3-E1 osteoblasts resulted in an increase in Runx2 P1 promoter activity and endogenous Runx2 expression as well as an increase in osteoblast differentiation markers. Conversely, osteoblasts derived from Pkd1 m1Bei homozygous mutant mice had significant reductions in endogenous Runx2 expression, osteoblastic markers, and differentiation capacity ex vivo. Co-expression of constitutively active PC1 C-terminal construct into Pkd1 m1Bei homozygous osteoblasts was sufficient to normalize Runx2 P1 promoter activity. These findings are consistent with a possible functional role of cilia and PC1 in anabolic signaling in osteoblasts/osteocytes.
mal dominant polycystic kidney disease is caused by inactivating mutations of PKD1 (which produces polycystin-1 (PC1)) or PKD2 (which produces polycystin-2 (PC2)) (1) . Also, mutations of Tg737, kif3a, and cpk, which encode the ciliary proteins polaris, Kif3a, and cystin, cause autosomal recessive polycystic kidney disease (6 -9) . PC1 is a 4303-amino acid cell-surfaceexpressed protein that has a multidomain extracellular region, an 11 transmembrane region (10) , and an ϳ200 amino acid cytoplasmic C-terminal tail (3), whereas PC2 is a Ca 2ϩ -permeable cation channel belonging to the transient receptor potential family (11) (12) (13) . There is compelling evidence that PC1 forms heterodimers with PC2 to create a polycystin complex that localizes with Tg737, Kif3a, and Cpk in cilium and may be involved in cell-matrix interfaces and cell-cell contacts (1, 5, 9, 14) . The polycystin complex, either through its association with cilium or cell-to-cell or cell-to-matrix interactions, has been implicated as a mechano-sensor in renal epithelial cells (15) (16) (17) . Emerging data, however, favor a role of the polycystin complex as a flow sensor. In this regard, fluid shear increases intracellular Ca 2ϩ in wild-type epithelial cells (16, 18) , whereas cells with mutations in PKD1 or in which PC2 has been inactivated with an antibody do not activate flow-induced Ca 2ϩ signaling (16, 18, 19) . Whether the cilia-PC1/PC2 complex might play a more generalized role in mechano-sensing other tissues, such as bone, has not been examined.
Mechanical stimulation of the skeleton by exercise is an important anabolic signal in bone that leads to increased osteoblastic proliferation and matrix deposition (20 -23) , whereas the absence of mechanical stimulation, as occurs with immobilization, disuse, and exposure to low gravity, causes bone loss (24, 25) . Osteocytes, lining cells, and potentially osteoblasts are the key mechanosensitive cells in bone that transduce force or load into anabolic cell signals leading to new bone formation. Mechano-sensing in bone leads to the release of autocrine factors such as prostaglandin E2, prostacyclin I2, ATP, UTP, transforming growth factor ␤, fibroblast growth factor 2, insulin-like growth factors, and nitric oxide (20 -22, 26 ). Runx2 appears to be a downstream target, since this essential osteoblastic transcription factor is up-regulated by mechanical strain, extracellular nucleotides, and oxidative stress in osteoblasts (27) (28) (29) (30) (31) (32) , and bone loss due to unloading is exacerbated in heterozygous Runx2-deficient mice (33) . Runx2 also regulates the expression of genes, such as cyclooxygenase-2, osteopontin, osterix, osteocalcin, and ␣ 1 (I) procollagen, which are all induced by mechanical strain (20, 34) .
Several primary mechano-sensing molecules in bone have been proposed, including several G-protein-coupled receptors (e.g. prostaglandin and purinergic receptors), integrin receptors, connexins/gap-junctions, and stretch-activated and purinergic channels as well as cell-to-cell and cell-to-matrix interactions (20 -22, 26) . The initial mechano-sensing event that stimulates the release of osteogenic factors and the activation of second messengers leading to the osteo-inductive response, however, has not been established. The possibility that polycystin 1 may be involved in mechano-sensing in osteoblasts/osteocytes, however, is suggested by the observation that Pkd1 null mice have abnormal skeletal development characterized by spina bifida occulta and osteochondrodysplasia (35) (36) (37) . Although cilia-like structures have been reported in bone cells, definitive proof of cilia in osteoblasts/osteocytes is lacking (38 -40) . Mechanical strain in bone can generate interstitial fluid flow that exerts fluid shear stress on bone cells and stretches tissues; however, that could potentially activate PC1 and cilia (23) .
In the current study, we examined whether osteoblasts/osteocytes express Pkd1 and Pkd2 and other cilia genes, determined whether mono cilia are present in these cells, assessed the skeletal phenotype in Pkd1 m1Bei mice that have an inactivating missense mutation in the Pkd1 gene (37) , and evaluated the function of PC1 in osteoblasts ex vivo. We have found evidence for the presence of polycystin complexes and cilia in osteoblasts/osteocytes that are coupled to Runx2-dependent regulation of osteoblast/osteocyte function.
EXPERIMENTAL PROCEDURES

Mice-Pkd1
m1Bei heterozygous mice, which has an inactivating point mutation in Pkd1 gene caused by ENU mutagenesis leading to substitution of an arginine for methionine in the first transmembrane domain of the PC1 protein (37), were obtained from mutant Mouse Regional Resource Center (University of North Carolina). These mice were bred and maintained on a C57BL/6J background. The mice were genotyped using SYBR Green (Bio-Rad) real-time PCR reagents, extracted genomic DNA, and the following primers: wild-type (T allele) forward primer, 5Ј-CTG GTG ACC TAT GTG GTC AT-3Ј; mutant (G allele) forward primer, 5Ј-CTG GTG ACC TAT GTG GTC AG-3Ј; common reverse primer, 5Ј-AGC CGG TCT TAA CAA GTA TTT C-3Ј. The Pkd1 allele discrimination was determined by delayed signal on one mismatch. Animal experiments were performed after review and approval by University of Kansas Medical Center's Animal Care and Use Committee.
Cell Cultures and Transient or Stable Transfections-MLO-Y4, osteocyte-like cells, were plated onto culture dishes coated with rat tail type I collagen, whereas the MC3T3-E1 cells were plated directly onto the plastic culture dish. For total RNA isolation, MC3T3-E1 cells were cultured in ␣-minimal essential medium containing 10% fetal calf serum supplemented with 5 mM ␤-glycerophosphate and 25 g/ml ascorbic acid for 4, 7, and 14 days, whereas MLO-Y4 cells were cultured in ␣-minimal essential medium supplemented with 5% fetal bovine serum and 5% calf serum for 4, 7, and 14 days. For transient transfections, 1 ϫ 10 6 MC3T3-E1 or MLO-Y4 cells were transfected with either control expression vector, gain-of-function, or lossof-function PC1 C-tail constructs along with the Runx2-P1 luciferase reporter (p1.4Runx2-P1-Luc) construct by using the electroporation protocol from Amaxas Biosystems as described by the manufacturer (Amaxa, Inc.). A total of 6.6 g of plasmid DNA was used for each electroporation, with 3.6 g of PC1 C-tail construct, 2.4 g of p1.4Runx2-P1-Luc reporter, and 0.6 g of Renilla luciferase-null (RL-null) as the internal control plasmid. Promoter activity was assessed by measuring luciferase activity 48 h after transfection. The cells were then lysed in Passive lysis buffer (Promega), and 20 l of cell lysate was used with the dual luciferase assay kit (Promega) using an EG&G Berthold 9507 luminometer. Stable transfection of MC3T3-E1 was performed by a protocol that maintains the differentiation potential of these osteoblasts as previously described (41) . Briefly, MC3T3-E1 cells were only transfected with 6.0 g of PC1 C-tail fusion construct and selected by incubation in media containing 500 g/ml G418 (Invitrogen) 48 h after transfection.
Measurement of Alkaline Phosphatase Activity and Mineralization Assays in Immortalized Osteoblast Cultures-Calvaria from Pkd1
m1Bei E15.5 embryos were used for the isolation of osteoblasts by sequential collagenase digestion as previously described (42, 43) . To engineer immortal osteoblast cell lines, isolated primary osteoblasts were infected using a retroviral vector carrying SV40 large and small T antigen. To induce differentiation, immortalized osteoblasts were plated at a density of 1 ϫ 10 5 cells/well in a 6-well plate and grown for a period of up to 14 days in ␣-minimal essential medium containing 10% fetal calf serum supplemented with 5 mM ␤-glycerophosphate and 25 g/ml ascorbic acid. Alkaline phosphatase activity and alizarin red-S histochemical staining for mineralization were performed as previously described (42) . Total DNA content was measured with a PicoGreen double-stranded DNA quantitation reagent and kit (Molecular Probes, Eugene, OR).
RT-PCR Analysis-RT-PCR was done using the Titan TM One tube RT-PCR kit from Roche Applied Science. DNase I-treated total RNA (1.0 g) was reverse-transcribed into cDNA with the reverse primer described before (44) . The reverse transcription reaction was incubated at 50°C for 30 min. PCR was performed with thermal cycling parameters of 94°C for 30 s, 60°C for 30 s, and 68°C for 30 s for 35 cycles followed by final extension at 68°C for 7 min. To amplify mouse Pkd1 transcript, we used the forward primer (5Ј-CAT TGT ACC CCT GGA GGA GA-3Ј) in combination with the reverse primer (5Ј-GAT GTC CAG GCT GTT TCG AT-3Ј). To amplify mouse Pkd2 transcript, we used the forward primer (5Ј-GGG GCT GCT ACA GTT TCT TG-3Ј) with the reverse primer (5Ј-CCG GAG ACT CTC TGA GAT GG-3Ј). The mouse Tg737 transcript was RT-PCR-amplified using the forward primer (5Ј-TCC AAC TGA TTC CCA AGC TC-3Ј) and the reverse primer (5Ј-TGG CAC TCA GTC GTT CAC TC-3Ј). Mouse glyceraldehyde-3-phosphate dehydrogenase was amplified as a control for the RT-PCR reactions.
Immunofluorescence-MC3T3-E1 osteoblasts and MLO-Y4 osteocytes were grown on collagen-coated coverslips and kept at confluence for at least 3 days. At the end of the culture the cells were washed 3 times with PBS, then fixed with cold 4% paraformaldehyde, 0.2% Triton for 10 min at room temperature and washed with PBS 3 times. The coverslips were incubated for 30 min in 1% bovine serum albumin before incubation with the primary acetylated ␣-tubulin antibody (Sigma-Aldrich, T6793) for 1 h at room temperature. After washing 3 times in PBS, they were treated with secondary Texas Red-labeled antimouse IgG (Jackson ImmunoResearch, 715-076-150) in 1% bovine serum albumin for 1 h at room temperature and washed 3 times in PBS before mounting with ProLong Gold antifade reagent (Invitrogen, P36935). Nuclei were counterstained with 4,6-diamidino-2-phenylindole. Photographs were taken under a microscope with magnifications of 60ϫ.
Whole Mount Calvaria Immunostaining-For whole-mount bone immunostaining for ␣-tubulin, transgenic mice expressing the topaz variant of enhanced green fluorescent protein (eGFP-tpz) targeted to the osteocyte were used (45) . These mice were kindly provided by Dr. David Rowe (University of Connecticut Health Center, Farmington, CT 06030). The GFP reporter was expressed under control of a 7892-bp fragment of the dentin matrix protein-1 (Dmp1) promoter together with a 4439-bp region containing the first exon, the first intron, and part of exon 2. In these mice GFP is expressed almost exclusively in osteocytes and preosteocytes. This transgenic mouse model, therefore, provides an extremely useful tool for imaging of osteocytes either in situ within the bones or in cell cultures (45) (46) (47) .
Whole calvaria from 12-day-old neonatal Dmp1-GFP mice were excised, and the periostea was carefully removed under a dissection microscope. The bones were fixed overnight at 4°C in the dark in neutral-buffered formalin. The bones were then washed twice in PBS for 15 min with shaking. Next, the bones were decalcified for 1 week in 10% EDTA followed by washing 3 times in PBS at 4°C for 15 min. Background blocking was performed overnight at 4°C in PBS, 1% normal horse serum, 0.05% sodium azide followed by washing twice with PBS. Because the primary antibody was a mouse monoclonal against ␣-tubulin (Sigma-Aldrich, T 6793), the Vectastain-Elite kit was used according to manufacturer's instructions to block endogenous mouse immunoglobulin. The bones were incubated for 4 h at room temperature with primary antibody diluted in Vectastain-Elite diluent. After 4 washes in PBS, the bones were then incubated for 2 h with a Cy3-conjugated donkey anti-mouse second antibody diluted 1:250 in Vectastain-Elite diluent (Jackson Immunoresearch Laboratories Inc., West Grove, PA). The bones were then washed four times in PBS and counterstained with 4,6-diamidino-2-phenylindole nuclear stain (4 g/ml in PBS) for 30 s followed by two final PBS washes. The whole bones were mounted under a coverslip in 2 drops of 9:1 glycerol:PBS containing 5% N-propyl gallate as an anti-fade reagent. The specimens were viewed on a Nikon E800 microscope under epifluorescent illumination. Digital photographs were acquired from multiple optical planes using an optronics CCD camera driven by the AnalySIS software (Olympus Soft Imaging Solutions Corp, Lakewood, CO). Extended focus images were generated using this software.
Scanning Electron Microscopy-Renal tubular Madin-Darby canine kidney cells and MLO-Y4 cells were cultured on Thermanox coverslips and at the end of the culture washed with PBS and fixed with 10% formalin for 20 min, washed again with PBS, dehydrated in graded concentrations of ethanol, and dried using hexamethyldisilazone for 5 min. After dehydration, the coverslips were mounted on a stub, sputtered with gold-palladium, and viewed with the FEI/Philips XL30 Field emission environmental scanning electron microscope (48) .
Whole Skeletal Mount Alizarin Red/Alcian Blue Staining and Histological Preparation-This procedure provides information regarding developmental abnormalities. Embryos from 13.5 (E13.5) to 15.5 (E15.5) days of gestation were collected and fixed for more than 3 days in 95% ethanol. Samples were defatted for 2-3 days in acetone and stained sequentially with Alcian blue and alizarin red S in 2% KOH. The stained skeleton preparations were cleared with 1% KOH, 20% glycerol and stored in 50% EtOH, 50% glycerol (42) . Femurs from E15.5 embryos were decalcified at 4°C in 12.5% EDTA and 2.5% paraformaldehyde in phosphate-buffered saline. Longitudinal sections were stained with hematoxylin and eosin to assess the histology of the growth plate and bone marrow cavity in femurs (42) .
Microcomputed Tomography Analysis-The distal femoral metaphyses were scanned using a CT 40 (Scanco Medical AG, Bassersdorf, Switzerland) and 167 slices of the metaphyses under the growth plate, constituting 1.0 mm in length, were selected. The three-dimensional images were generated using the following values for a gauss filter (0.8, support 1) and a threshold of 275. A three-dimensional image analysis was done to determine bone volume (BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.Th), and trabecular separation (Tb.Sp). Cortical bone was measured on the mid-shaft region of cortical bone. 50 slices of the diaphysis, 0.3 mm in length, were selected. The mean cortical thickness was determined by distance measurements at eight different points on the cortical slice (42) .
Real-time RT-PCR and Western
Blot-For quantitative realtime RT-PCR, 2.0 g total RNA isolated from whole E15.5 embryos and femurs of 12-week-old mice was reverse-transcribed as described (42) . PCR reactions contained a 100-ng template (cDNA or RNA), 300 nM each forward and reverse primer, and 1ϫ iQ TM SYBR Green Supermix (Bio-Rad) in 50 l. Samples were amplified for 40 cycles in an iCycler iQ TM real-time PCR detection system with an initial melt at 95°C for 10 min followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. PCR product accumulation was monitored at multiple points during each cycle by measuring the increase in fluorescence caused by the binding of SybrGreen I to double-stranded DNA. The threshold cycle (Ct) of tested-gene product from the indicated genotype was normalized to the Ct for 18 S rRNA (49) . Nuclear extracts were prepared using NE-PER TM (Pierce). Protein concentrations were determined with a Bio-Rad protein assay kit (Bio-Rad). Equal quantities of protein were subjected to NuPAGE TM 4 -12% Bis-Tris gel (Invitrogen) and were analyzed with standard Western blot protocols (horseradish peroxidase-conjugated secondary antibodies from Santa Cruz Biotechnology and ECL from Amersham Biosciences). RUNX2 (sc-10758) and lamin A/C (sc-6215) antibodies from Santa Cruz Biotechnology were used according to the manufacturer's instructions (44) .
Bone Densitometry and Bone Histomorphometric AnalysisBone mineral density (BMD) of femurs was assessed at 12 weeks of age using a LUNARPIXIMUS bone densitometer (Lunar Corp., Madison, WI) as previously described (50) . Skeletons of mice were prelabeled with calcein (Sigma C-0875, 30 g/g of body weight) by intraperitoneal injection at days 1 and 5 in 12-week-old mice before collection of tibias. Tibias were removed from 12-week-old mice, fixed in 70% ethanol, and processed for methyl methacrylate embedding by using Osteo-Bed Bone Embedding kit (Polysciences, Inc.) (50). 10-m cross-sections of tibia at the joint of tibia and fibula were evaluated under fluorescent light as reported previously (51) by our laboratory. We determined mineral apposition rate based on histomorphometry standards; endocortical and periosteal surfaces were analyzed separately.
Serum Biochemistry-Serum osteocalcin levels were measured using a mouse osteocalcin EIA kit (Biomedical Technologies Inc. Stoughton, MA). Serum urea nitrogen (BUN) was determined using a BUN diagnostic kit from Pointe Scientific, Inc. Serum calcium was measured by the colorimetric cresolphthalein binding method, and phosphorus was measured by the phosphomolybdate-ascorbic acid method (Stanbio Laboratory, TX). Serum osteoprotegerin (OPG) and free secreted RANK ligand (sRANKL) were measured using mouse enzymelinked immunosorbent assay (ELISA) kits (Quantikine, R&D systems and Biomedical Medizinprodukte GmbH & Co. KG), and serum TRAP was assayed with the ELISA-based SBA Sciences mouseTRAP TM assay (Suomen Bioanalytiikka Oy). Statistics-We evaluated differences between groups by oneway analysis of variance. All values are expressed as the means Ϯ S.E. All computations were performed using the Statgraphic statistical graphics system (STSC Inc.).
RESULTS
Evidence for Expression of Pkd1 and Pkd2 and the Presence of
Cilia in Osteoblasts/Osteocytes-To investigate the possibility that Pkd1/Pkd2 and possibly cilia are present in bone cells, we examined if Pkd1, Pkd2, and the cilia-associated polaris (Tg737) and Kif3a transcripts are present in osteoblast and osteocyte cell lines. By RT-PCR we demonstrated that confluent cultures of MC3T3-E1 osteoblasts and MLO-Y4 osteocytes express Pkd1 and Pkd2 as well as polaris (Tg737) and Kif3a transcripts (Fig. 1A) . To determine whether osteoblasts and osteocytes express cilialike structures, we examined MC3T3-E1 and MLO-Y4 cells as well as wild-type (Pkd1 ϩ/ϩ ) and Pkd1 homozygous osteoblasts (Pkd1 m1Bei/m1Bei ) by immunofluorescence (Fig. 1B) and scanning electron microscopy ( Fig. 1C) and primary osteocytes by whole mount calvaria immunostaining (Fig. 1D) . As a control for our methods for demonstrating the presence of primary cilia, we used cilia expressing renal tubular derived MadinDarby canine kidney cells as a positive control. These cells have been shown to express cilia by immunohistochemical analysis using an antibody to ␣-tubulin (52) and by scanning electron microscopy (48) . Both confluent MC3T3-E1 osteoblast and MLO-Y4 osteocyte-like cell lines (Fig. 1B, upper two panels) displayed punctuate and linear staining with the ␣-tubulin antibody, consistent with the presence of single cilia-like structure per cell. We have also observed cilia in Pkd1 ϩ/ϩ and Pkd1 m1Bei/m1Bei osteoblasts (Fig. 1B, lower two panels) . The presence of cilia in Pkd1 homozygous osteoblasts is expected, since Pkd1 is known not to be required for ciliogenesis. A single cilia-like structure measuring 2-4 m in length was also detected by scanning electron microscopy extending from the membrane surface in both Madin-Darby canine kidney cells (Fig. 1C, left panel) and MLO-Y4 (Fig. 1C, right panel) cells. In addition, the whole mount immunostaining of 12-day-old mouse calvaria showed ␣-tubulin positive structures resembling primary cilia in primary osteocytes (Fig. 1D, upper panel, GFP positive cells with dendrites) and primary osteoblasts Fig. 1D, lower panel (35, 36) . In wildtype mice, we observed the anticipated development from an unmineralized cartilaginous bone template at E13.5 to a caudal progression of mineralization beginning with the skull, mandible, and ribs by E14.5 and continuing with the spine and long bones by E15.5 ( Fig. 2A) . In contrast, in Pkd1 m1Bei/miBei mice we observed abnormalities in endochondral bone formation. In E14.5 Pkd1 m1Bei/miBei embryos the cartilaginous skeleton was completely formed, but calcification was completely absent (Fig. 2A) . However, at E15.5 Pkd1 m1Bei/miBei embryos displayed evidence of calcification, but the amount of mineralized bone was less than in wild-type controls ( Fig. 2A) . Defects were observed in both the calvaria and long bones, suggesting a delay in both intramembranous and endochondral bone formation.
Histological analysis confirmed the delay in endochondral ossification in long bones of E15.5 Pkd1 m1Bei/miBei embryos (Fig. 2B) . Homozygous Pkd1 m1Bei mice were characterized by delay in vascular invasion, resulting in the absence of a bone marrow cavity. These mice also exhibited a narrow bone collar. We also observed abnormalities in bone in heterozygous Pkd1 m1Bei mice (Pkd1 ϩ/m1Bei ) that were not apparent in the whole skeletal preparations. In this regard Pkd1 ϩ/m1Bei displayed a reduced size of the bone marrow cavity, consistent with delayed conversion of the cartilaginous structure to primary spongiosa (Fig. 2B) .
Runx2, a master gene regulating bone development, exists as two major gene products, Runx2-I derived from the P2 proximal promoter and Runx2-II (formerly called Osf2 or Cbfa1) derived from the P1 distal promoter (36, 37) . Because the skeleton of Pkd1 m1Bei/miBei embryos resembled the skeletal phenotype in mice with selective Runx2-II deficiency (42), we determined if loss of polycystin-1 results in abnormalities of Runx2 expression. Runx2-I and Runx2-II mRNA levels in total RNA isolated from E15.5 embryos were quantified by real-time RT-PCR. A gene dose-dependent reduction in Runx2-II expression was observed, with levels being less in Pkd1 m1Bei homozygous embryos compared with Pkd1 m1Bei heterozygous embryos (Fig. 2C) . In contrast, no differences were observed in Runx2-I isoform expression in the different genotypes (Fig. 2C) .
To investigate whether mutant Pkd1 m1Bei and the consequent reduction in Runx2-II expression resulted in concomitant defects in downstream gene expression, we examined by real-time RT-PCR the expression levels of osteoblast (osteocalcin, osterix, OPG, and RANKL)-and osteoclast (tartrateresistant acid phosphatase (TRAP)-specific transcripts in wild-type, heterozygous Pkd1 ϩ/m1Bei , and homozygous Pkd1 m1Bei/m1Bei embryos. Similar to the reduction in Runx2-II, a gene dose-dependent reduction in osteocalcin and osterix expressions was observed in wild-type and Pkd1 m1Bei mutant embryos, and a significant reduction in others transcripts in homozygous Pkd1 m1Bei/m1Bei embryos was also found (Fig. 2D) . 
Osteopenia in Heterozygous Pkd1 m1Bei Mice Suggests a Postnatal Role for Pkd1 in Bone-The homozygous Pkd1
m1Bei/m1Bei mice are embryonic lethal, thereby precluding assessment of the bone phenotype postnatally. To determine the impact of loss of one functional Pkd1 allele in the adult, we assessed BMD in 12-week-old male and female wild-type and heterozygous Pkd1 ϩ/m1Bei mice, which have normal survival and no apparent histological abnormalities of the kidney (data not shown). As shown in Fig. 3A ,
Pkd1
ϩ/m1Bei heterozygous mice have a 9% reduction in BMD. CT analysis revealed that the reduction in bone mass in Pkd1 ϩ/m1Bei heterozygous mice was caused by a reduction in trabecular bone volume (33%) and cortical bone thickness (6%) (Fig. 3B) . In addition, histological analysis of bone identified a significant decrease in mineral apposition rate in 12-weekold Pkd1 ϩ/m1Bei mice compared with age-matched wild-type Pkd1 ϩ/ϩ mice (Fig. 3C) , suggesting impaired osteoblast-mediated bone formation. Further evidence for osteoblast dysfunction includes a reduction in Runx2-II and osterix expression (Fig. 3D) as well as osteocalcin, osteoprotegerin, and RANK ligand in bone and serum from heterozygous Pkd1
mice at 12 weeks of age ( Fig. 3D and Table 1 ). Serum levels and bone expression of TRAP, a marker of bone resorption, were also reduced in heterozygous Pkd1 ϩ/m1Bei compared with wildtype littermates (Fig. 3D and Table  1 ). These findings suggest that low bone formation rates rather than increased resorption contribute to the low BMD (Fig. 3, A-C) and bone volume of femurs observed in heterozygous Pkd1 ϩ/m1Bei mice (Fig. 3B) .
Osteoblasts from E15.5 Pkd1
m1Bei/m1Bei Mutant Mice Exhibit Defective Differentiation ex Vivo-To confirm the presence of a primary effect of PC1 on osteoblasts, we characterized the differentiation potential of osteoblasts derived from homozygous Pkd1 m1Bei/m1Bei embryos. Consistent with the reduction in Runx2-II expression in bone of Pkd1 m1Bei/m1Bei homozygous mice, we found that osteoblasts derived from Pkd1 m1Bei/m1Bei homozygous mice also displayed significant reductions in both Runx2 mRNA and protein levels (Fig. 4A) as well as reduced P1 Runx2 promoter activity (Fig. 5C ). We also found that osteoblastic gene makers, including osteocalcin, osteopontin, osterix, and ␣ 1 (I) procollagen, were significantly decreased in Pkd1 m1Bei/m1Bei homozygous osteoblasts (data not shown). In addition, Pkd1 m1Bei/m1Bei osteoblasts displayed time-dependent increments in DNA content during the first 10 days in differentiation medium, but the DNA content was significantly lower at different time points compared with Pkd1 ϩ/ϩ osteoblasts (Fig. 4B ), indicating that there was a proliferation defect in Pkd1 m1Bei/m1Bei osteoblasts under differentiating conditions. We also found that mutant PC1 impairs osteoblastic differentiation and maturation, as evidenced by lower alkaline phosphatase activity Significant difference from wild-type Pkd1 ϩ/ϩ mice at p Ͻ 0.05 was by one-way analysis of variance. Osteocalcin, OPG, and free secreted RANKL were produced by osteoblasts, and TRAP was produced by osteoclasts.
and mineralization of extracellular matrix as assessed by alizarin red S staining in Pkd1 m1Bei/m1Bei compared with wild-type osteoblast cultures grown for up to 14 days under differentiating conditions (Fig. 4, C and D) .
Pkd1 (PC1) C-tail (Gain-of-function) Constructs Regulate the Runx2 Expression in
Osteoblasts/Osteocytes-Activation of PC1 signaling can be achieved by overexpression of the C terminus of PC1 (53) . To confirm that the defect in Runx2 expression results from mutant PC1, we explored the function of PC1 in osteoblasts/osteocytes by overexpressing PC1 C-tail (gain-of-function) constructs (Fig. 5A) . The PC1-LT construct is composed of human IgG CH2-CH3 region, TM region, and entire C-tail containing the regions for G-protein activation and the coiled-coil region that is required for coupling to PC2, PC1-HT contains a limited G-protein signaling domain, PC1-LS contains only the G-protein signaling domain, and PC1-AT contains only the coiledcoil region (Fig. 5A) . Transient cotransfection of all constructs along with the Runx2 P1 promoter-reporter construct into MC3T3-E1 osteoblasts significantly increased Runx2 P1 promoter activity ( Fig  5B) . The response was greater for the PC1-HT and PC1-AT constructs containing the coiled-coil domain. The activation of the Runx2 P1 promoter was significantly less with the PC1-LS domain containing only the site for G-protein coupling (Fig. 5B) . Identical results were also observed in MLO-Y4 osteocytes (data not shown). We also examined the effects of overexpression of the PC1 C-tail constructs on Runx2 P1 promoter activity in Pkd1 m1Bei/m1Bei osteoblasts (Fig. 5C ). Transient co-transfection of the PC1-AT and P1 promoter constructs restored Runx2 P1 promoter activity in Pkd1 m1Bei/m1Bei osteoblasts to levels observed in wild-type Pkd1 ϩ/ϩ osteoblasts (Fig. 5C ). Next, we examined whether the PC1 C-tail construct PC1-AT regulates endogenous Runx2 and bone-related gene expression in MC3T3-E1 osteoblasts. Consistent with the stimulation of Runx2 P1 promoter activity, we also observed significant increases of endogenous Runx2 message expression (Fig. 5D ) as well as its downstream genes osteocalcin, osterix, osteoprotegerin, and Rank ligand (Fig. 5E ) in MC3T3-E1 stably transfected with the PC1-AT construct containing the coiled-coil domain. These findings are consistent with Pkd1 coupling to Runx2 expression and osteoblast differentiation.
DISCUSSION
The PC1/PC2 complex and cilia are an established paradigm for sensing mechanical strain and possibly other stimuli and regulating differentiation in kidney epithelial cells (16, 17, 19) . Despite two studies reporting skeletal abnormalities in Pkd1 null mice (35) (36) (37) and unconfirmed reports of cilia-like structures in osteoblasts/osteocytes by electron microscopy (38) , the expression of the PC1/PC2 complex and cilia and their functional role in osteoblasts/osteocytes has not been investigated m1Bei/m1Bei osteoblasts displayed time-dependent increments in DNA content during 10 days of culture in differentiation medium, but the DNA content was significantly lower at different time points compared with Pkd1 ϩ/ϩ osteoblasts. C, quantification of mineralization. Alizarin Red-S stain was extracted with 10% cetylpyridinium chloride and quantified as described under "Experimental Procedures." Pkd1 m1Bei/m1Bei osteoblasts had time-dependent increments in Alizarin red-S accumulation during 14 days of culture, but the accumulation was significantly lower at different time points compared with Pkd1 ϩ/ϩ osteoblasts. D, alkaline phosphatase activity. Pkd1 m1Bei/m1Bei osteoblasts displayed time-dependent increments in alkaline phosphatase activities during 14 days of culture, but the alkaline phosphatase activity was significantly lower at different time points compared with Pkd1 ϩ/ϩ osteoblasts. Data are the mean Ϯ S.E. from at least three independent experiments. The asterisk indicates significant difference from wild-type Pkd1 ϩ/ϩ at p Ͻ 0.05 by one-way analysis of variance. Values sharing the same letter superscript are not significantly different at p Ͻ 0.05.
in detail. In this work, we provide evidence that the Pkd1 and Pkd2 gene productions, PC1 and PC2, are expressed along with cilia-related transcripts and cilia-like structures in osteoblasts/osteocytes. More importantly, we demonstrate that mutant PC1 is associated with a gene dose-dependent defect in bone development, decreased expression of the osteogenic Runx2 transcription factor, and impaired osteoblast-mediated bone formation in vivo and ex vivo, consistent with an anabolic function of the Pkd1 gene product in osteoblasts/osteocytes.
PC1 is known to be widely expressed and developmentally regulated in many tissues and cell types (54, 55) . Prior studies regarding bone, however, have been limited to embryonic tissues (35, 36) , and we are aware of no studies that have examined the expression of PC1 or PC2 in the osteoblast lineage or assessed the function of polycystins postnatally. Our studies are the first to demonstrate the presence of Pkd1 and its associated Pkd2 transcripts in bone mechano-sensing osteoblasts/osteocytes. Indeed, we demonstrated that Pkd1 and Pkd2 transcripts and transcripts associated with cilia are expressed in osteoblasts/osteocytes cell lines (Fig. 1) . Primary cilia-like structures were also identified on the membrane surface of osteoblastic and osteocyte-like cell lines as well as primary osteocytes and osteoblasts in situ by immunostaining with anti-␣-tubulin antibody (Fig.  1 ). Federman and Nichols (38) reported the presence of primary cilia in rat calvarial osteocytes over 30 years ago (39) , but this observation has not been widely accepted. Our findings clearly show the presence of a single cilium in postnatal primary osteocytes/osteoblasts in bone and in osteoblastic and osteocyte-like cell lines (Fig. 1, B-D) .
We also provide additional information regarding PC1 function in bone through the characterization of the Pkd1 m1Bei mutant mouse, whose skeletal phenotype has not been previously described. We found a delay in endochondral bone formation during embryogenesis in the Pkd1 m1Bei homozygous mice (Fig. 2) , similar to reported skeletal developmental abnormalities described in other Pkd1-deficient mouse models. The complete absence of a functional Pkd1 gene resulted in a delay in endochondral and intramembranous bone formation in vivo and an intrinsic abnormality of osteoblast function ex vivo, as evidenced by the defective maturation of osteoblasts derived from calvaria of E15.5 Pkd1 m1Bei/m1Bei embryos. Transcripts for markers of osteoblast function, including Runx2, osterix, and osteocalcin, were also reduced in Pkd1 m1Bei/m1Bei homozygous mouse embryos (Figs. 2 and 4) .
We also discovered a postnatal reduction in osteoblast-mediated bone formation in heterozygous Pkd1 ϩ/m1Bei mice that has not been previously reported (35) (36) (37) (Fig. 3) . The phenotype of heterozygous mutant mice was less severe than Pkd1 m1Bei/m1Bei homozygous mice, consisting of reduced BMD and trabecular bone volume due to diminished osteoblast-mediated bone formation, as evidenced by low mineral apposition rates, diminished osteoblast markers, and the absence of increased bone resorption (Fig. 3 and Table 1 ). A gene dose-dependent effect of Pkd1 on osteoblast-mediated bone formation implicates PC1 as a potential mediator of osteoblast function. Abnormalities of skeletogenesis in Pkd1 m1Bei mutant mice could be solely due to the demonstrable abnormalities in the osteoblasts lineage or also involve defects in the function of chondrocytes, which also express cilia (56, 57) .
We also show that PC1 is an important regulator of osteoblast function through regulation of Runx2-dependent signaling both in vivo and in vitro. In this regard we found evidence that Runx2-II, an essential transcriptional factor in controlling osteoblast-mediated bone formation, is downstream of Pkd1. Interestingly, the diminished metaphyseal bone volume and lower mineral apposition rate of Pkd1-deficient mice resembled the phenotype of selective Runx2-II-deficient mice (50) . Moreover, we found evidence for a selective and gene dose-dependent reduction in the Runx2-II message levels in both embryos and bone of Pkd1 m1Bei mutant adult mice. In contrast, the Runx2-I isoform was not altered in either embryos or adult long bones. Finally, overexpression of constitutively active C-terminal PC1 chimeric constructs (53) into MC3T3-E1 and MLO-Y4 osteocytes resulted in stimulation of Runx2-II P1 promoter activity, endogenous Runx2-II transcripts, and osteoblast differentiation markers (Fig. 5) .
Although we did not directly study PC2 function in these studies, the observation that the PC1 C-terminal constructs containing the coil-coiled domain, which is known to couple PC1 with PC2 (11, 58) , are more potent stimulators of Runx2 expression, indirectly implicates a role of PC2. In addition, we have evidence for lower intracellular calcium levels in Pkd1 m1Bei/m1Bei homozygous osteoblasts consistent with abnormal coupling to PC2 (data not shown). Further studies are needed to investigate the potential role of PC2-dependent regulation of intracellular calcium in mediating PC1 stimulation of Runx2 expression.
Our studies also did not establish a functional link between cilia and polycystin function or their roles as mechano-sensors in bone. Although the functional association of polycystin and cilia in renal epithelia cells implies a similar function in osteoblasts/osteocytes, polycystins might also have function independent of cilia in bone. In this regard extracellular domain of PC1 may serve as a connection between cells and mediate stretch-sensitive cell-cell interactions (20 -22) . Alternatively, perturbations of the polycystin complex on the dendrite membrane could lead to changes in the cytoskeleton (59) . In addition, cilia may have functions other than mechano-sensing and actions that are independent of polycystins (57, 60) . Further studies are needed to establish a physical association between PC1, PC2, and cilia in osteoblasts/osteocytes to establish that selective loss of PC1, PC2, and cilia in osteoblasts/osteocytes results in defective mechano-sensing in bone and to elucidate the precise downstream signal transduction mechanism linking PC1 to activation of Runx2.
In conclusion, our data show that osteoblasts/osteocytes have cilia and express the cilia-associated Pkd1 and Pkd2 gene products, PC1 and PC2. Based on the phenotype changes in bone and ex vivo function of osteoblasts/osteocytes from Pkd1 mutant mice; we suggest that polycystin-1 is important for normal bone development and osteoblast/osteocyte-mediated bone formation. Cilia-polycystins are also a candidate for the elusive primary "mechano-sensor" in bone. Additional studies are warranted, however, to determine whether the cilia-PC1/ PC2 complex is part of a skeletal mechano-sensing mechanism that allows osteoblasts/osteocytes to sense and transduce mechanical forces into anabolic cell signals leading to new bone formation.
